Storyboard

New mRNA anti-tick vaccine may protect from more than just Lyme disease

The vaccine is based on the same mRNA technology that led to the extraordinarily successful rapid development of COVID-19 vaccines in 2020. But instead of directing cells in the body to produce spike proteins to train the body to attack SARS-CoV-2, this particular vaccine directs cells to produce a number of proteins found in the saliva of the black-legged tick Ixodes scapularis.

Avatar - New Atlas
Curated by
New Atlas
    • Science
    • Life Sciences
    • Health
    • Medical Technology
    • Health Care Technology
New mRNA anti-tick vaccine may protect from more than just Lyme disease
Continue to read
7 stories in this Storyboard

More stories from Science